ConductScience.org, home

Paper36216730

How cancer cells make and respond to interferon-I.

Cheon H and 4 others. Trends Cancer, 2023. Cited by 146 papers, by iCite.

Cite this record

ConductScience Library. How cancer cells make and respond to interferon-I. Papers, record 36216730. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36216730

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
How cancer cells make and respond to interferon-I.
PubMed
Journal
Trends Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
146
iCite
Relative citation ratio, by iCite
11.4
iCite
Revised in PubMed
2024-06-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cheon HHyeonJoo
2Wang YYuxin
3Wightman SMSamantha M
4Jackson MWMark W
5Stark GRGeorge R

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InterferonsMajor topic
NeoplasmsMajor topic
Humans
Interferon-Stimulated Gene Factor 3
Interferon-Stimulated Gene Factor 3, gamma Subunit
Signal Transduction
Tyrosine

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA062220NCI NIH HHSUnited StatesP01CA062220PubMed and NIHNIH RePORTER
R01 CA252224NCI NIH HHSUnited StatesR01CA252224PubMed and NIHNIH RePORTER
R03 CA215941NCI NIH HHSUnited StatesR03CA215941PubMed and NIHNIH RePORTER
R21 CA252387NCI NIH HHSUnited StatesR21CA252387PubMed and NIHNIH RePORTER

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125692705DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity.Immunity2015https://conductscience.org/library/papers/25692705PubMed
231497205Expression profile and prognostic values of STAT family members in non-small cell lung cancer.Am J Transl Res2019https://conductscience.org/library/papers/31497205PubMed
330557977Several genes involved in the JAK-STAT pathway may act as prognostic markers in pancreatic cancer identified by microarray data analysis.Medicine (Baltimore)2018https://conductscience.org/library/papers/30557977PubMed
435004284Oncolytic Viruses and Cancer, Do You Know the Main Mechanism?Front Oncol2021https://conductscience.org/library/papers/35004284PubMed
528728846The effects of type I interferon on glioblastoma cancer stem cells.Biochem Biophys Res Commun2017https://conductscience.org/library/papers/28728846PubMed
624434553RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24434553PubMed
733849964Can Biomarkers Guide Oncolytic Virus Immunotherapy?Clin Cancer Res2021https://conductscience.org/library/papers/33849964PubMed
830853213LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation.Cell Metab2019https://conductscience.org/library/papers/30853213PubMed
928442624Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.Sci Signal2017https://conductscience.org/library/papers/28442624PubMed
1025344738Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.Nat Med2014https://conductscience.org/library/papers/25344738PubMed
1134795058The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34795058PubMed
1234799452PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34799452PubMed
1331817234Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications.Cancers (Basel)2019https://conductscience.org/library/papers/31817234PubMed
1428579323Type I Interferon in Chronic Virus Infection and Cancer.Trends Immunol2017https://conductscience.org/library/papers/28579323PubMed
1522820642Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape.Nat Med2012https://conductscience.org/library/papers/22820642PubMed
1632759968A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses.Cell Res2021https://conductscience.org/library/papers/32759968PubMed
1724434209Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.Cancer Cell2014https://conductscience.org/library/papers/24434209PubMed
1816490214The human LINE-1 retrotransposon creates DNA double-strand breaks.J Mol Biol2006https://conductscience.org/library/papers/16490214PubMed
1924065129IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.EMBO J2013https://conductscience.org/library/papers/24065129PubMed
2027791205Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.Oncotarget2016https://conductscience.org/library/papers/27791205PubMed

See all 61 referencesDownload CSV of references

Cited by106

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
42983473Integrated single-nucleus and spatial transcriptomics define tumour cell metaprograms and tumour microenvironment organisation in choroid plexus tumours.Genome Med2026https://conductscience.org/library/papers/42983473PubMed
42982877Deubiquitinases at the crossroads of T-cell immunity and tumor immune evasion.Cell Mol Immunol2026https://conductscience.org/library/papers/42982877PubMed
42981393IFNAR1 stabilization sustains CD8+ T cell persistence in IFN-high colorectal cancer liver metastases.Sci Adv2026https://conductscience.org/library/papers/42981393PubMed
42939477A Biomimetic In Vitro Model of the Pro-Inflammatory Microenvironment Recapitulates Type I/II Interferon Signaling and Refractory Acute Monocytic Leukemia.Biology (Basel)2026https://conductscience.org/library/papers/42939477PubMed
42744865Viral mimicry escape as a necessary feature of malignant transformation.Nat Rev Cancer2026https://conductscience.org/library/papers/42744865PubMed
42512286Plasma-Derived sEVs from HNSCC Patients Differentially Regulate NF-κB Signaling in Macrophages Depending on the HPV Status.Cancers (Basel)2026https://conductscience.org/library/papers/42512286PubMed
42495531KMT5A-mediated methylation of IRF3 promotes tumor progression through immune suppression.iScience2026https://conductscience.org/library/papers/42495531PubMed
42428769Natural and Engineered Cytokines as Cancer Therapeutics.Annu Rev Cancer Biol2026https://conductscience.org/library/papers/42428769PubMed
42297776Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis.Nat Commun2026https://conductscience.org/library/papers/42297776PubMed
42245637Endogenous retroviruses and response to immune checkpoint inhibitors: mechanisms, clinical evidence, and therapeutic implications.Front Immunol2026https://conductscience.org/library/papers/42245637PubMed
42200421Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma.Mol Oncol2026https://conductscience.org/library/papers/42200421PubMed
42190606BRCA1 deficiency induces NFκB-dependent type-I interferon signaling in fallopian tube epithelial cells.Neoplasia2026https://conductscience.org/library/papers/42190606PubMed
42180981Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.Transl Cancer Res2026https://conductscience.org/library/papers/42180981PubMed
42112708Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy.Cancer Immunol Res2026https://conductscience.org/library/papers/42112708PubMed
41963303Targeting the epigenome and the integrated stress response to normalize colorectal cancer subclonal plasticity and progression.Cell Death Dis2026https://conductscience.org/library/papers/41963303PubMed
41959390Sustained interferon exposure creates a hyper-metastatic subset of melanoma cells.bioRxiv2026https://conductscience.org/library/papers/41959390PubMed
41885070Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma.Mol Cancer Ther2026https://conductscience.org/library/papers/41885070PubMed
41872684Striking the right balance with type I interferon signalling in cancer.Nat Rev Cancer2026https://conductscience.org/library/papers/41872684PubMed
41820027The Effect of Interferon Type I Adjuvant Therapy on the Lifespan and Complications of Glioma Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis.Cancer Rep (Hoboken)2026https://conductscience.org/library/papers/41820027PubMed
41815915Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias.Front Pharmacol2026https://conductscience.org/library/papers/41815915PubMed

See all 106 cited byDownload CSV of cited by

Genes32

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AIFM19131PubTator's text mininghttps://conductscience.org/library/genes/9131NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CDK51020PubTator's text mininghttps://conductscience.org/library/genes/1020NCBI Gene
CGAS115004PubTator's text mininghttps://conductscience.org/library/genes/115004NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
DHX5879132PubTator's text mininghttps://conductscience.org/library/genes/79132NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
IFIH164135PubTator's text mininghttps://conductscience.org/library/genes/64135NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNAR13454PubTator's text mininghttps://conductscience.org/library/genes/3454NCBI Gene
IFNAR23455PubTator's text mininghttps://conductscience.org/library/genes/3455NCBI Gene
IFNB13456PubTator's text mininghttps://conductscience.org/library/genes/3456NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
IRF910379PubTator's text mininghttps://conductscience.org/library/genes/10379NCBI Gene
JAK13716PubTator's text mininghttps://conductscience.org/library/genes/3716NCBI Gene
MAVS57506PubTator's text mininghttps://conductscience.org/library/genes/57506NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
OAS14938PubTator's text mininghttps://conductscience.org/library/genes/4938NCBI Gene

See all 32 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36216730

GET https://conductscience.org/api/papers/v1/36216730/references?page=2